Gabelli Healthcare & WellnessRx Trust Declares First Quarter Distribution of $0.17 per Share

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) declared a $0.17 per share cash distribution payable March 24, 2026 to shareholders of record March 17, 2026. The Board sets quarterly distributions and may add an adjusting December distribution to satisfy RIC minimums. The Fund estimates the 2026 distribution mix as ~2% net investment income, ~38% net capital gains and ~60% return of capital on a book basis; final tax components will be determined after year-end and reported on Form 1099-DIV in early 2027.

Positive

• Quarterly cash distribution of $0.17 per share
• Payable date set: March 24, 2026 with record date March 17, 2026
• Board retains flexibility to fund adjusting December distribution

Negative

• 60% of the 2026 distribution estimated as return of capital on a book basis
• Only 2% estimated from net investment income for current distribution

News Market Reaction

%

1 alert

% News Effect

On the day this news was published, GAMI declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

RYE, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & Wellness^Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable on March 24, 2026 to common shareholders of record on March 17, 2026.

The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.

Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently 20% in taxable accounts for individuals (or less depending on an individual’s tax bracket). In addition, certain U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their "net investment income", which includes dividends received from the Fund and capital gains from the sale or other disposition of shares of the Fund.

If the Fund does not generate sufficient earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.

Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro-rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, the current distribution paid to common shareholders in 2026 would include approximately 2% from net investment income, 38% from net capital gains and 60% would be deemed a return of capital on a book basis. This does not represent information for tax reporting purposes. The estimated components of each distribution are updated and provided to shareholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). The final determination of the sources of all distributions in 2026 will be made after year end and can vary from the quarterly estimates. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution. All individual shareholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2026 distributions in early 2027 via Form 1099-DIV.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:

Bethany Uhlein
(914) 921-5546

About The Gabelli Healthcare & Wellness^Rx Trust
The Gabelli Healthcare & Wellness^Rx Trust is a diversified, closed-end management investment company with $233 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (OTCQX: GAMI).

NYSE: GRX
CUSIP – 36246K103

Investor Relations Contact:
Bethany Uhlein
914.921.5546
buhlein@gabelli.com

FAQ

How much is Gabelli Healthcare & WellnessRx Trust (GRX) paying for the March 2026 distribution?

The Fund declared a $0.17 per share cash distribution payable March 24, 2026. According to Gabelli Healthcare & WellnessRx Trust, shareholders of record on March 17, 2026 will receive the payment, with tax components finalized after year-end.

What are the tax components of GRX's 2026 distributions and how much is return of capital?

Approximately 60% of the 2026 distribution is estimated as return of capital on a book basis. According to Gabelli Healthcare & WellnessRx Trust, estimates also show about 38% net capital gains and 2% net investment income; final allocations will be reported after year-end.

When will GRX shareholders receive tax reporting for 2026 distributions (Form 1099-DIV)?

Individual shareholders will receive Form 1099-DIV in early 2027 detailing distribution components and tax treatment. According to Gabelli Healthcare & WellnessRx Trust, final source determinations for 2026 distributions will be made after year-end and included in that reporting.

Does the Gabelli Healthcare & WellnessRx Trust plan additional distributions beyond quarterly payments in 2026?

The Board may pay an adjusting distribution in December to meet RIC minimum distribution requirements. According to Gabelli Healthcare & WellnessRx Trust, this adjusting payment would include any additional income and net realized capital gains in excess of quarterly distributions.

Will the GRX distribution indicate the Fund's investment performance for 2026?

No; shareholders should not infer investment performance solely from the distribution amount. According to Gabelli Healthcare & WellnessRx Trust, distributions reflect income, realized gains, or return of capital and are not a direct measure of total return or NAV performance.